
Tirzepatide + Glycine (Starter Dose, 3 Months)
Tirzepatide is the first medication that acts on two gut hormones at once: GLP-1 and GIP. Together, these signals reduce appetite, slow digestion and improve how your body handles sugar and fat.
- Strength
- Provider-prescribed dose
- Prescription
- Required, after consultation
Prices shown are what the treatment costs once it has been prescribed.
Continue with Scriptful here on our site, or open it in a new tab if needed.
About this treatment
Tirzepatide is the first medication that acts on two gut hormones at once: GLP-1 and GIP. Together, these signals reduce appetite, slow digestion and improve how your body handles sugar and fat.
Because it works on two pathways, tirzepatide is one of the most effective weight-loss medications studied to date. Our formula is compounded with the amino acid glycine. Research suggests tirzepatide may:
Significantly reduce appetite and food cravings
Support substantial, sustained weight loss alongside healthy eating and activity
Improve blood sugar control and insulin sensitivity
Support better blood pressure, cholesterol and overall metabolic health
Who it’s for
Adults new to tirzepatide who have a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, prediabetes or high cholesterol.
How it works
Tirzepatide is a once-weekly subcutaneous injection that you do yourself at home. This starter plan covers your first 3 months, beginning at 2.5 mg per week and increasing gradually to reduce side effects. A licensed provider reviews your health history before prescribing and adjusts your plan as you go. Nausea, constipation or fullness are common early on and usually ease with time.
What’s included
A 3-month supply of prescription medication compounded by a licensed pharmacy, a provider consultation, injection supplies (needles and alcohol prep pads), and priority shipping at $15 flat fee.
Important safety information
Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro® or Zepbound®. Individual results vary. It isn’t recommended if you or a family member have had medullary thyroid cancer or MEN 2, or if you have a history of pancreatitis, type 1 diabetes, or are pregnant, breastfeeding or planning a pregnancy. A provider will determine whether it’s right for you.
Details
| Presentation | Injection |
|---|---|
| Route | Subcutaneous |
| Strength | Provider-prescribed dose |
| Supply | 3-month plan; 1 × 2 mL vial |
Also in Weight Management.

Semaglutide + Glycine (Starter Dose, 3 Months)

Semaglutide + Glycine (Any Dose, 3 Months)
